Infecciones en cirugía

Infecciones complejas: manejo quirúrgico y antibiótico (1º Parte)

Esta actualización educacional se enfoca en el manejo de estrategias para las infecciones intraabdominales y las infecciones complicadas de la piel y sus anexos.

Autor/a: Dres. Napolitano LM, Sawyer RG, Stevens DL.

Fuente: Contemporary Surgery, Supplement, December 2006.

Indice
1. Bibliografía
2. Desarrollo

Bibliografía - Introducción

1. Most Common Diagnoses and Procedures in U.S. Community Hospitals, 1996. Available at: http://www.ahrq.gov/data/hcup/commdx. Accessed November 6, 2006.
2. Malangoni MA. Evaluation and management of tertiary peritonitis. Am Surg. 2000;66:157-161.
3. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004;53(suppl 2):ii37-ii50.

Bibliografía - Texto

1. Laroche M, Harding G. Primary and secondary peritonitis: an update. Eur J Clin Microbiol Infect Dis. 1998;17:542-550.
2. Barie PS. Management of complicated intra-abdominal infections. J Chemother. 1999;11:464-477.
3. Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23:486-494.
4. Nathens AB, Rotstein OD, Marshall JC. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg. 1998;22:158-163.
5. Raymond DP, Kuehnert MJ, Sawyer RG. Preventing antimicrobial-resistant bacterial infections in surgical patients. Surg Infect (Larchmt). 2002;3:375-385.
6. Gorbach SL. Microbiology of the gastrointestinal tract. Available at: http://gsbs.utmb.edu/microbook/ch095.htm. Accessed November 6, 2006.
7. Goldstein EJ. Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. Clin Infect Dis. 2002;35(suppl 1):S106-S111.
8. Roehrborn A, Thomas L, Potreck O, et al. The microbiology of postoperative peritonitis. Clin Infect Dis. 2001;33:1513-1519.
9. Barie PS, Williams MD, McCollam JS, et al, for the PROWESS Surgical Evaluation Committee. Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg. 2004;188:212-220.
10. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997-1005.
11. Mazuski JE, Sawyer RG, Nathens AB, et al, for the Therapeutic Agents Committee of the Surgical Infections Society. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt). 2002;3:161-173.
12. Mazuski JE, Sawyer RG, Nathens AB, et al, for the Therapeutic Agents Committee of the Surgical Infections Society. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt). 2002;3:175-233.
13. Krobot K, Yin D, Zhang Q, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004;23:682-687.
14. Chow JW, Satishchandran V, Snyder TA, Harvey CM, Friedland IR, Dinubile MJ. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt). 2005;6:439-448.
15. Malangoni MA, Song J, Herrington J, Choudhri S, Pertel P. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg. 2006;244:204-211.
16. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, for the Tigecycline 301 and 306 Study Groups. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005;41(suppl 5):S354-S367.
17. Schein M, Wittmann DH, Lorenz W. Duration of antibiotic treatment in surgical infections of the abdomen. Forum statement: a plea for selective and controlled postoperative antibiotic administration. Eur J Surg Suppl. 1996;576:66-69.